ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,555.74
-0.19%
US Tech 100
19,120.00
-0.90%
Dow Jones
40,358.09
-0.14%
Brent Oil
80.775
-0.91%
Bitcoin
65,998.56
-2.38%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Puma Biotechnology Inc (PBYI)

  7. Puma Biotechnology Inc (PBYI) News

PBYI

Puma Biotechnology (PBYI)

Puma Biotechnology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PBYI
DateTimeSourceHeadlineSymbolCompany
07/18/20247:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
07/18/20247:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
07/18/20246:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
07/18/20244:10PMBusiness WirePuma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
07/17/20248:43PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
07/17/20248:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
07/17/20248:36PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
07/02/20245:30PMBusiness WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
06/17/20247:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
06/17/20247:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
06/17/20247:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
06/17/20247:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
06/13/20249:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
06/13/20249:44PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
06/13/20249:43PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
06/13/20249:41PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
06/07/20245:37PMBusiness WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
06/03/20242:33PMBusiness WirePuma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung CancerNASDAQ:PBYIPuma Biotechnology Inc
06/02/202410:01AMBusiness WirePuma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)NASDAQ:PBYIPuma Biotechnology Inc
05/28/20249:00AMBusiness WirePuma Biotechnology to Join Russell 3000 IndexNASDAQ:PBYIPuma Biotechnology Inc
05/23/20245:15PMBusiness WirePuma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual MeetingNASDAQ:PBYIPuma Biotechnology Inc
05/17/20244:43PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
05/02/20244:05PMBusiness WirePuma Biotechnology Reports First Quarter Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
04/18/20244:15PMBusiness WirePuma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
04/03/20245:30PMBusiness WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
03/20/20248:30AMBusiness WirePuma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast CancerNASDAQ:PBYIPuma Biotechnology Inc
02/29/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
02/29/20244:05PMBusiness WirePuma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
02/27/20246:30PMBusiness WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
02/22/20244:10PMBusiness WirePuma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care ConferenceNASDAQ:PBYIPuma Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:PBYI

Your Recent History

USOTC
ITUP
Interups (CE)
USOTC
AABB
Asia Broadband (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
SFLM
SFLMaven (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
KEGS
1812 Brewing (PK)
NYSE
AMC
AMC Entertainment
NASDAQ
NB
NioCorp Developments
NASDAQ
TSLA
Tesla
USOTC
SPZI
Spooz (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
IDVV
International Endeavors (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
RDGL
Vivos (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved